Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

February 26, 2020Open Access

Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

ClinicalTrials.gov Identifier: NCT01206062.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Vaduganathan et al. (Wed,) studied this question.

synapsesocial.com/papers/69d88db38c03fbaff8bef598 https://doi.org/https://doi.org/10.1001/jamacardio.2019.6192

Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis2014 · 789 citations
2Estimated Long-Term Survival With Eplerenone2019 · 9 citations
3The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)2014 · 547 citations
4Communication Strategies for Sharing Prognostic Information With Patients2019 · 59 citations
5Trends in Cardiometabolic Mortality in the United States, 1999-20172019 · 155 citations